These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4783660)

  • 81. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Immunity of children in Kharkov against poliomyelitis].
    Nosatenko AI; Gruntovskaia LG; Golub OG; Ivanova RB; Nikitina RK
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jan; (1):96-100. PubMed ID: 6301175
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A serological survey of responses to immunization with Sabin vaccine in the Australian Capital Territory.
    Withell J; Green A; Spears AD; Thom AS
    Med J Aust; 1970 Mar; 1(10):485-90. PubMed ID: 5440993
    [No Abstract]   [Full Text] [Related]  

  • 84. Comparison of maternal and cord serum titres for measles and for rubella antibodies.
    Brouwer R; de Groot IG; Verheij FB
    Arch Gesamte Virusforsch; 1974; 44(3):237-42. PubMed ID: 4209455
    [No Abstract]   [Full Text] [Related]  

  • 85. [The distribution of measles antibodies among different classes of immunoglobulins].
    Tikhonova NT; Khrometskaia TM; Kholchev NV; Strel'tsova MP; Ignat'eva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jun; 50(6):27-33. PubMed ID: 4780909
    [No Abstract]   [Full Text] [Related]  

  • 86. Neutralization test survey with three types of poliomyelitis viruses in children of San Francisco, Mexico City and Guam.
    HAMMON WM; SATHER G
    Am J Hyg; 1953 Mar; 57(2):185-193. PubMed ID: 13030456
    [No Abstract]   [Full Text] [Related]  

  • 87. HL-A linked genetic control of immune response in man.
    Haverkorn MJ; Hofman B; Masurel N; Rood JJ
    Transplant Rev; 1975; 22():120-4. PubMed ID: 1167710
    [No Abstract]   [Full Text] [Related]  

  • 88. Substandard/counterfeit antimicrobial drugs.
    Kelesidis T; Falagas ME
    Clin Microbiol Rev; 2015 Apr; 28(2):443-64. PubMed ID: 25788516
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Vaccines should be more environmentally stable.
    Arya SC
    BMJ; 1993 Apr; 306(6885):1130. PubMed ID: 8495184
    [No Abstract]   [Full Text] [Related]  

  • 90. Ideal age for measles vaccination with persisting maternal antibody, human immunodeficiency virus infection and protein-calorie malnutrition.
    Arya SC
    Infection; 1993; 21(4):256-7. PubMed ID: 8225633
    [No Abstract]   [Full Text] [Related]  

  • 91. A better system for polio vaccination in developing countries?
    Arya SC
    Br Med J; 1980 Oct; 281(6245):943. PubMed ID: 7427516
    [No Abstract]   [Full Text] [Related]  

  • 92. Poliomyelitis serosurveillance in adolescent population.
    Arya SC
    Br Med J (Clin Res Ed); 1981 Aug; 283(6290):558-9. PubMed ID: 6266578
    [No Abstract]   [Full Text] [Related]  

  • 93. Persistence of poliovirus-neutralizing antibodies 2-16 years after immunization with live attenuated vaccine. A seroepidemiologic survey in the mainland of Venice.
    Trivello R; Renzulli G; Farisano G; Bonello C; Moschen M; Gasparini V; Benussi G
    Epidemiol Infect; 1988 Dec; 101(3):605-9. PubMed ID: 2850939
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The response to oral poliovaccine in persons aged 16-18 years.
    Smith JW; Lee JA; Fletcher WB; Morris CA; Parker DA; Yetts R; Magrathe DI; Perkins FT
    J Hyg (Lond); 1976 Apr; 76(2):235-47. PubMed ID: 177700
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Immune status of children one to four years of age as determined by history and antibody measurement.
    Gold E; Fevrier A; Hatch MH; Herrmann KL; Jones WL; Krugman RD; Parkman PD
    N Engl J Med; 1973 Aug; 289(5):231-5. PubMed ID: 4351596
    [No Abstract]   [Full Text] [Related]  

  • 96. Antibody status to poliomyelitis, measles, rubella, diphtheria and tetanus, Ontario, 1969-70: deficiencies discovered and remedies required.
    MacLeod DR; Ing WK; Belcourt RJ; Pearson EW; Bell JS
    Can Med Assoc J; 1975 Oct; 113(7):619-23. PubMed ID: 1181016
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Combined administration of measles, mumps, rubella, and trivalent oral poliovirus vaccines.
    Krugman RD; Witte JJ; Parkman PD; Herrmann KL; Meyer HM; Wende RD; Meyer BC; Dungca R
    Public Health Rep; 1977; 92(3):220-2. PubMed ID: 866558
    [No Abstract]   [Full Text] [Related]  

  • 98. Need for monitoring vaccinated populations for immunity levels.
    Horstmann DM
    Prog Med Virol; 1973; 16():215-40. PubMed ID: 4585486
    [No Abstract]   [Full Text] [Related]  

  • 99. Inadequate poliovirus immunity levels in immunized Illinois children.
    Rasmussen CM; Thomas CW; Mulrooney RJ; Morrissey RA
    Am J Dis Child; 1973 Oct; 126(4):465-9. PubMed ID: 4783660
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.